Published randomized controlled trials of surveillance in cancer patients - a systematic review

Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 2016;66:271-9. DOI: https://doi.org/10.3322/caac.21349

Frangioni JV. New technologies for human cancer imaging. J Clin Oncol 2008;26:4012. DOI: https://doi.org/10.1200/JCO.2007.14.3065

Merkow RP, Korenstein D, Yeahia R, et al. Quality of cancer surveillance clinical practice guidelines: specificity and consistency of recommendations. JAMA Intern Med 2017;177:701-9. DOI: https://doi.org/10.1001/jamainternmed.2017.0079

Sokolenko AP, Imyanitov EN. Molecular diagnostics in clinical oncology. Front Mol Biosci 2018;5:76. DOI: https://doi.org/10.3389/fmolb.2018.00076

Brenner DJ, Hall EJ. Computed tomography - an increasing source of radiation exposure. N Engl J Med 2007;357:2277-84. DOI: https://doi.org/10.1056/NEJMra072149

Longo C, Deber R, Fitch M, et al. An examination of cancer patients’ monthly ‘out‐of‐pocket’costs in Ontario, Canada. Eur J Cancer Care (Engl) 2007;16:500-7. DOI: https://doi.org/10.1111/j.1365-2354.2007.00783.x

Goel A, Christy ME, Virgo KS, et al. Costs of follow-up after potentially curative treatment for extremity soft-tissue sarcoma. Int J Oncol 2004;25:429-35. DOI: https://doi.org/10.3892/ijo.25.2.429

Tzeng C-WD, Abbott DE, Cantor SB, et al. Frequency and intensity of postoperative surveillance after curative treatment of pancreatic cancer: a cost-effectiveness analysis. Ann Surg Oncol 2013;20:2197-203. DOI: https://doi.org/10.1245/s10434-013-2889-6

Wu JX, Beni CE, Zanocco KA, et al. Cost-effectiveness of long-term every three-year versus annual postoperative surveillance for low-risk papillary thyroid cancer. Thyroid 2015;25:797-803. DOI: https://doi.org/10.1089/thy.2014.0617

American Society of Clinical Oncology. Five things physicians and patients should question; Published online 2013. Available from: https://www.choosingwisely.org/wp-content/uploads/2015/02/ASCO-Choosing-Wisely-List.pdf

National Comprehensive Cancer Network. Development and Update of the NCCN Guidelines.; Published online 2020. Available from: https://www.nccn.org/professionals/development.aspx

Wright JG. A practical guide to assigning levels of evidence. JBJS. 2007;89:1128-30. DOI: https://doi.org/10.2106/JBJS.F.01380

Kanters S, Ford N, Druyts E, et al. Use of network meta-analysis in clinical guidelines. Bull World Health Organ 2016;94:782-4. DOI: https://doi.org/10.2471/BLT.16.174326

Bhandari M, Devereaux P, Montori V, et al. Users’ guide to the surgical literature: how to use a systematic literature review and meta-analysis. Can J Surg. 2004;47:60.

Greenland S. A critical look at some popular meta-analytic methods [invited commentary]. Am J Epidemiol 1994;140:290-6. DOI: https://doi.org/10.1093/oxfordjournals.aje.a117248

Haidich AB. Meta-analysis in medical research. Hippokratia 2010;14:29-37.

American Society of Clinical Oncology. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology. J Clin Oncol 1996;14:671-9. DOI: https://doi.org/10.1200/JCO.1996.14.2.671

Scottish Intercollegiate Guidelines. Search Filters; Published online 2019. Available from: https://www.sign.ac.uk/search-filters.html

Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928. DOI: https://doi.org/10.1136/bmj.d5928

Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg 2012;10:28-55. DOI: https://doi.org/10.1016/j.ijsu.2011.10.001

Ghezzi P, Magnanini S, Rinaldini M, et al. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: a multicenter randomized controlled trial. JAMA 1994;271:1587-92. DOI: https://doi.org/10.1001/jama.1994.03510440047031

Kjeldsen B, Kronborg O, Fenger C, Jørgensen O. A prospective randomized study of follow‐up after radical surgery for colorectal cancer. Br J Surg. 1997;84:666-9. DOI: https://doi.org/10.1002/bjs.1800840523

Koinberg I-L, Fridlund B, Engholm G-B, Holmberg L. Nurse-led follow-up on demand or by a physician after breast cancer surgery: a randomised study. Eur J Oncol Nurs 2004;8:109-17. DOI: https://doi.org/10.1016/j.ejon.2003.12.005

Kokko R, Hakama M, Holli K. Role of chest X-ray in diagnosis of the first breast cancer relapse: a randomized trial. Breast Cancer Res Treat 2003;81:33-9. DOI: https://doi.org/10.1023/A:1025419114857

Kokko R, Hakama M, Holli K. Follow-up cost of breast cancer patients with localized disease after primary treatment: a randomized trial. Breast Cancer Res Treat 2005;93:255-60. DOI: https://doi.org/10.1007/s10549-005-5199-2

Mäkelä J, Laitinen S, Kairaluoma M. Early results of follow-up after radical resection for colorectal cancer. Preliminary results of a prospective randomized trial. Surg Oncol 1992;1:157-61. DOI: https://doi.org/10.1016/0960-7404(92)90029-K

Mäkelä JT, Laitinen SO, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer: results of a prospective randomized trial. Arch Surg 1995;130:1062-7. DOI: https://doi.org/10.1001/archsurg.1995.01430100040009

Monteil J, Vergnenègre A, Bertin F, et al. Randomized follow-up study of resected NSCLC patients: conventional versus 18F-DG coincidence imaging. Anticancer Res 2010;30:3811-6.

Ohlsson B, Breland U, Ekberg H, et al. Follow-up after curative surgery for colorectal carcinoma. Dis Colon Rectum 1995;38:619-26. DOI: https://doi.org/10.1007/BF02054122

Pietra N, Sarli L, Costi R, et al. Role of follow-up in management of local recurrences of colorectal cancer. Dis Colon Rectum 1998;41:1127-33. DOI: https://doi.org/10.1007/BF02239434

Primrose JN, Perera R, Gray A, et al. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA 2014;311:263-70. DOI: https://doi.org/10.1001/jama.2013.285718

Puri A, Ranganathan P, Gulia A, et al. Does a less intensive surveillance protocol affect the survival of patients after treatment of a sarcoma of the limb? updated results of the randomized toss study. Bone Jt J 2018;100:262-8. DOI: https://doi.org/10.1302/0301-620X.100B2.BJJ-2017-0789.R1

Puri A, Gulia A, Hawaldar R, et al. Does intensity of surveillance affect survival after surgery for sarcomas? Results of a randomized noninferiority trial. Clin Orthop Relat Res 2014;472:1568-75. DOI: https://doi.org/10.1007/s11999-013-3385-9

Rodríguez-Moranta F, Saló J, Arcusa À, et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol 2006;24:386-93. DOI: https://doi.org/10.1200/JCO.2005.02.0826

Rosati G, Ambrosini G, Barni S, et al. A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma. Ann Oncol 2016;27:274-80. DOI: https://doi.org/10.1093/annonc/mdv541

Rosselli Del Turco M, Palli D, Cariddi A, et al. Intensive diagnostic follow-up after treatment of primary breast cancer: a randomized trial. JAMA-J Am Med Assoc-US Ed. 1994;271:1593-7. DOI: https://doi.org/10.1001/jama.271.20.1593

Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 1998;114:7-14. DOI: https://doi.org/10.1016/S0016-5085(98)70626-2

Secco GB, Fardelli R, Gianquinto D, et al. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol 2002;28:418-23. DOI: https://doi.org/10.1053/ejso.2001.1250

Sobhani I, Itti E, Luciani A, et al. Colorectal cancer (CRC) monitoring by 6-monthly 18FDG-PET/CT: an open-label multicenter randomised trial. Ann Oncol 2018;29:931-7. DOI: https://doi.org/10.1093/annonc/mdy031

Wang T, Cui Y, Huang W-S, et al. The role of postoperative colonoscopic surveillance after radical surgery for colorectal cancer: a prospective, randomized clinical study. Gastrointest Endosc 2009;69:609-15. DOI: https://doi.org/10.1016/j.gie.2008.05.017

Wattchow DA, Weller DP, Esterman A, et al. General practice vs surgical-based follow-up for patients with colon cancer: randomised controlled trial. Br J Cancer 2006;94:1116-21. DOI: https://doi.org/10.1038/sj.bjc.6603052

Pita-Fernández S, Alhayek-Ai M, Gonzalez-Martin C, et al. Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis. Ann Oncol 2015;26:644-56. DOI: https://doi.org/10.1093/annonc/mdu543

Renehan AG, Egger M, Saunders MP, O’Dwyer S. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 2002;324:813. DOI: https://doi.org/10.1136/bmj.324.7341.813

Figueredo A, Rumble RB, Maroun J, et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer 2003;3:26. DOI: https://doi.org/10.1186/1471-2407-3-26

Jeffery M, Hickey BE, Hider PN. Follow‐up strategies for patients treated for non‐metastatic colorectal cancer. Cochrane Database Syst Rev 2019 [Epub ahead of print]. DOI: https://doi.org/10.1002/14651858.CD002200.pub4

Tjandra JJ, Chan MK. Follow-up after curative resection of colorectal cancer: a meta-analysis. Dis Colon Rectum 2007;50:1783-99. DOI: https://doi.org/10.1007/s10350-007-9030-5

Unverzagt S, Prondzinsky R, Peinemann F. Single-center trials tend to provide larger treatment effects than multicenter trials: a systematic review. J Clin Epidemiol 2013;66:1271-80. DOI: https://doi.org/10.1016/j.jclinepi.2013.05.016

Pelc NJ. Recent and future directions in CT imaging. Ann Biomed Eng 2014;42:260-8. DOI: https://doi.org/10.1007/s10439-014-0974-z

Palumbo MO, Kavan P, Miller W, et al. Systemic cancer therapy: achievements and challenges that lie ahead. Front Pharmacol 2013;4:57. DOI: https://doi.org/10.3389/fphar.2013.00057

Augestad KM, Norum J, Dehof S, et al. Cost-effectiveness and quality of life in surgeon versus general practitioner-organised colon cancer surveillance: a randomised controlled trial. BMJ Open 2013;3:e002391. DOI: https://doi.org/10.1136/bmjopen-2012-002391

留言 (0)

沒有登入
gif